Literature DB >> 11731598

Disability and difference: balancing social and physical constructions.

T Koch1.   

Abstract

The world of disability theory is currently divided between those who insist it reflects a physical fact affecting life quality and those who believe disability is defined by social prejudice. Despite a dialogue spanning bioethical, medical and social scientific literatures the differences between opposing views remains persistent. The result is similar to a figure-ground paradox in which one can see only part of a picture at any moment. This paper attempts to find areas of commonality between the opposing camps, and thus to rearrange the figures of the paradox at a fundamental level. The purpose is first to identify areas in which common ground can be achieved, and secondarily, to clarify the areas in which disagreement continues. While a general and unified theory of physical difference/disability is beyond the scope of this paper the result may advance that general goal.

Mesh:

Year:  2001        PMID: 11731598      PMCID: PMC1733470          DOI: 10.1136/jme.27.6.370

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  8 in total

1.  Life quality vs the 'quality of life': assumptions underlying prospective quality of life instruments in health care planning.

Authors:  T Koch
Journal:  Soc Sci Med       Date:  2000-08       Impact factor: 4.634

2.  Disability, gene therapy and eugenics--a challenge to John Harris.

Authors:  S M Reindal
Journal:  J Med Ethics       Date:  2000-04       Impact factor: 2.903

3.  Is there a coherent social conception of disability?

Authors:  J Harris
Journal:  J Med Ethics       Date:  2000-04       Impact factor: 2.903

4.  The social nature of disability, disease and genetics: a response to Gillam, Persson, Holtug, Draper and Chadwick.

Authors:  C Newell
Journal:  J Med Ethics       Date:  1999-04       Impact factor: 2.903

5.  Outrageous fortune: the risk of suicide in genetic testing for Huntington disease.

Authors:  T D Bird
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 6.  Future states: the axioms underlying prospective, future-oriented, health planning instruments.

Authors:  T Koch
Journal:  Soc Sci Med       Date:  2001-02       Impact factor: 4.634

7.  Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences.

Authors:  M Kuppermann; R F Nease; L A Learman; E Gates; B Blumberg; A E Washington
Journal:  Obstet Gynecol       Date:  2000-10       Impact factor: 7.661

8.  Against all odds: positive life experiences of people with advanced amyotrophic lateral sclerosis.

Authors:  J M Young; P McNicoll
Journal:  Health Soc Work       Date:  1998-02
  8 in total
  7 in total

Review 1.  Disability or end-of-life? Competing narratives in bioethics.

Authors:  Joseph Kaufert; Thomas Koch
Journal:  Theor Med Bioeth       Date:  2003

2.  The challenge of Terri Schiavo: lessons for bioethics.

Authors:  T Koch
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

3.  Looking for the meaning of dignity in the Bioethics Convention and the Cloning Protocol.

Authors:  Daniela-Ecaterina Cutas
Journal:  Health Care Anal       Date:  2005-12

4.  The ethicist as language czar, or cop: "end of life" v. "ending life".

Authors:  Tom Koch
Journal:  HEC Forum       Date:  2013-12

Review 5.  One principle and three fallacies of disability studies.

Authors:  J Harris
Journal:  J Med Ethics       Date:  2001-12       Impact factor: 2.903

6.  Eugenics and the genetic challenge, again: all dressed up and just everywhere to go.

Authors:  Tom Koch
Journal:  Camb Q Healthc Ethics       Date:  2011-04       Impact factor: 1.284

7.  The role of hope for health professionals in rehabilitation: A qualitative study on unfavorable prognosis communication.

Authors:  Mirjam Amati; Nicola Grignoli; Sara Rubinelli; Julia Amann; Claudia Zanini
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.